Close this search box.

NEW Update from Ron Davis: The Itaconate Pathway!

NEW Update from Ron Davis!

The Itaconate Pathway

Today, we are delighted to share the first in a series of research updates from Ronald W. Davis, PhD, Chair of OMF Scientific Advisory Board & Director of the OMF supported ME/CFS Collaborative Research Center at Stanford. 

In a new interview led by caregiver and advocate Janet Dafoe, Ron shares details about a project underway at the ME/CFS Collaborative Research Center at Stanford: The Itaconate Pathway study!




In 2014, Ron Davis and OMF’s Founder & CEO Linda Tannenbaum came together to build a scientific team of leading experts dedicated to solving ME/CFS and related multi-system chronic, complex diseases (msCCD). Since then, Ron has continued his urgent research while sharing his ideas, findings, and passion with OMF’s Collaborative Research Network.

At our OMF supported Centers, the researchers are eager to work together across multiple continents and disciplines and openly collaborate to find the solutions that will return millions to the healthy lives they deserve. We know one thing for sure: It will take a village to understand these diseases better and learn how to treat them properly. All silos need to be broken down. OMF is committed to building our “village” of experts, and we are incredibly excited to share these new research updates from Ron with the community. 

Stay tuned, as we will be sharing more video updates from Ron Davis in the coming weeks!  

* Learn more about some of these projects in Cort Johnson’s latest article on Health Rising! *



Support OMF’s Collaborative Research Network:

Want to take your gift to the next level? Become a monthly donor!

Your monthly contribution ensures that OMF supported researchers have the resources necessary to continue our mission of finding effective treatments and, ultimately, a cure.


Thank you for your support and for being a part of our OMF Family. 

We couldn’t do this without you!

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669